Por favor, use este identificador para citar o enlazar este ítem:
http://conacyt.repositorioinstitucional.mx/jspui/handle/1000/668| National Institute for the Infectious Diseases “L. Spallanzani” IRCCS. Recommendations for COVID-19 Clinical Management | |
| Nicastri, E Petrosillo, N Ippolito, G D’Offizi, G Marchioni, L Ascoli Bartoli, T Lepore, L Mondi, A Murachelli, S Antinori, A | |
| Acceso Abierto | |
| Atribución-NoComercial-SinDerivadas | |
| On January 9 2020, the World Health Organization (WHO) declared the identification, by Chinese Health authorities, of a novel coronavirus, further classified as SARS-CoV-2 responsible of a disease (COVID-19) ranging from asymptomatic cases to severe respiratory involvement. On March 9 2020, WHO declared COVID-19 a global pandemic. Italy is the second most affected country by COVID-19 infection after China. The "L. Spallanzani" National Institute for the Infectious Diseases, IRCCS, Rome, Italy, has been the first Italian hospital to admit and manage patients affected by COVID-19. Hereby, we show our recommendations for the management of COVID-19 patients, based on very limited clinical evidences; they should be considered as expert opinions, which may be modified according to newly produced literature data. | |
| Infectious Disease Reports | |
| 2020 | |
| Preimpreso | |
| https://coronavirus.1science.com/item/eeaa7e56e8e216ae746b09ed096700b7f796616e | |
| Inglés | |
| VIRUS RESPIRATORIOS | |
| Aparece en las colecciones: | Artículos científicos |
Cargar archivos:
| Fichero | Tamaño | Formato | |
|---|---|---|---|
| 101161.pdf | 405.66 kB | Adobe PDF | Visualizar/Abrir |